Resultados de Búsqueda

Evidencias COVID-19

Cochrane Portugal - Institute for Evidenced Based Health

These are preliminary data - some studies (22 clinical trials) are still ongoing, they do not support the use of convalescent plasma or hyperimune immunoglobulin in patients with COVID-19.

Evidencias COVID-19

Coronavirus (COVID-19): Evidence Collection. Evidence Aid

The COVID-19 pandemic is placing a strain on health care, with some services, such as surgery, particularly affected by the risks of transmission. In this rapid review, the authors searched for articles on COVID-19 and surgery in an emergency setting. They restricted their searches to articles published in English between 15 December 2019 and 30 March 2020. They included 12 articles. At the time of this review, the included studies showed that laparoscopic procedures should be deferred due to ...

Evidencias COVID-19

Coronavirus (COVID-19): Evidence Collection. Evidence Aid

COVID-19 is a respiratory infection and face masks are one type of physical barrier to help reduce the transmission of respiratory viruses from infected people. Mask use by symptomatic individuals can reduce transmission and may contribute to the benefits of face mask use in the wider community. Wearing face masks, especially N95 masks and respirators, can prevent coronavirus infection and that eye protection can provide additional benefits. The use of masks with hand sanitizer can reduce the ...

Evidencias COVID-19

Cochrane Portugal - Institute for Evidenced Based Health

The administration of hydroxychloroquine and / or azithromycin does not have any benefit in the hospital mortality of patients with Covid-19. Therapies that included hydroxychloroquine showed the highest rate of cardiac toxicity

Evidencias COVID-19

Cochrane Portugal - Institute for Evidenced Based Health

In all pathologies (COVID-19, SARS and MERS) there was an increase in the average length of hospital stay and nosocomial infections in patients who received glucocorticoids and, more importantly, the use of systemic glucocorticoids was associated with an increase mortality, either in Covid-19 (RR = 2.0 95% CI: 0.69 to 5.75), or in SARS (RR = 1.52 95% CI: 0.89 to 2.60 ), or in MERS (RR = 1.3, 95% CI 1.1 to 1.5). A high-quality RCT will be necessary to clarify this intervention in the referred ...